2927 — AFC-HD AMS Life Science Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeSmall CapTurnaround

Annual income statement for AFC-HD AMS Life Science Co, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.

	2020 August 31st	2021 August 31st	C2022 August 31st	2023 August 31st	2024 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15,819	22,368	23,025	25,579	30,185
Cost of Revenue
Gross Profit	4,555	6,865	8,583	9,323	10,492
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,821	20,126	22,118	24,051	28,317
Operating Profit	999	2,242	907	1,528	1,868
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,004	2,158	1,235	1,546	1,911
Provision for Income Taxes
Net Income After Taxes	677	1,495	738	1,107	1,245
Minority Interest
Net Income Before Extraordinary Items
Net Income	677	1,496	735	1,103	1,252
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	677	1,496	735	1,103	1,252
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	52.7	109	67.5	95.4	105
Dividends per Share